Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trialReena Khanna, Brian G. Feagan, Margaret K. Vandervoort et al.|The Lancet|2015Cited by 462
OP004 Early combined immunosuppression for the management of Crohn's disease: A community-based cluster randomized trialReena Khanna, Brian G. Feagan, Barrett G. Levesque et al.|Journal of Crohn s and Colitis|2014Cited by 19
1053 Early Combined Immunosuppression for the Management of Crohn's Disease: A Community-Based Cluster Randomized TrialReena Khanna, Brian G. Feagan, Barrett G. Levesque et al.|Gastroenterology|2014Cited by 10
Duodenal Villous Atrophy in a TTG-Negative Patient Taking Olmesartan: A Case Report and Review of the LiteratureTasha Kulai, John Igoe, Thomas Arnason et al.|Canadian Journal of Gastroenterology and Hepatology|2016Cited by 10
Severe sprue-like enteropathy associated with olmesartan.Tasha Kulai, John Igoe, Donald MacIntosh et al.|PubMed|2015Cited by 6